nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—DCK—Purine salvage—PNP—osteoporosis	0.0299	0.167	CbGpPWpGaD
Fludarabine—DCK—Purine metabolism—PNP—osteoporosis	0.0142	0.0792	CbGpPWpGaD
Fludarabine—DCK—Purine metabolism—ATIC—osteoporosis	0.0142	0.0792	CbGpPWpGaD
Fludarabine—Cladribine—PNP—osteoporosis	0.0131	1	CrCbGaD
Fludarabine—RRM1—Nucleotide metabolism—PNP—osteoporosis	0.00926	0.0517	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—ATIC—osteoporosis	0.00926	0.0517	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—PNP—osteoporosis	0.00713	0.0398	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—ATIC—osteoporosis	0.00713	0.0398	CbGpPWpGaD
Fludarabine—RRM1—Fulvestrant—Estradiol—osteoporosis	0.00698	0.336	CbGdCrCtD
Fludarabine—RRM1—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00482	0.0269	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00441	0.0246	CbGpPWpGaD
Fludarabine—DCK—Purine metabolism—GPX1—osteoporosis	0.00402	0.0224	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—GPX1—osteoporosis	0.00262	0.0146	CbGpPWpGaD
Fludarabine—DCK—Fulvestrant—Estradiol—osteoporosis	0.00249	0.12	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00244	0.0136	CbGpPWpGaD
Fludarabine—POLA1—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00237	0.114	CbGdCrCtD
Fludarabine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.00233	0.112	CbGdCrCtD
Fludarabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.00227	0.11	CbGdCrCtD
Fludarabine—POLA1—DNA Replication Pre-Initiation—PSMA2—osteoporosis	0.00217	0.0121	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication Pre-Initiation—PSMA5—osteoporosis	0.00217	0.0121	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—GPX1—osteoporosis	0.00202	0.0113	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—PSMA2—osteoporosis	0.0019	0.0106	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—PSMA5—osteoporosis	0.0019	0.0106	CbGpPWpGaD
Fludarabine—POLA1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00189	0.091	CbGdCrCtD
Fludarabine—POLA1—DNA Replication—PSMA2—osteoporosis	0.00178	0.00992	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—PSMA5—osteoporosis	0.00178	0.00992	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00173	0.00968	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—PSMA5—osteoporosis	0.00171	0.00955	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—PSMA2—osteoporosis	0.00171	0.00955	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00167	0.00932	CbGpPWpGaD
Fludarabine—DCK—Levorphanol—Estradiol—osteoporosis	0.00164	0.0792	CbGdCrCtD
Fludarabine—POLA1—S Phase—PSMA2—osteoporosis	0.00155	0.00867	CbGpPWpGaD
Fludarabine—POLA1—S Phase—PSMA5—osteoporosis	0.00155	0.00867	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00144	0.00805	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00144	0.00805	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00137	0.00766	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00125	0.00695	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—osteoporosis	0.00118	0.00659	CbGpPWpGaD
Fludarabine—Leukopenia—Pamidronate—osteoporosis	0.00109	0.00138	CcSEcCtD
Fludarabine—Alopecia—Conjugated Estrogens—osteoporosis	0.00109	0.00138	CcSEcCtD
Fludarabine—Constipation—Ibandronate—osteoporosis	0.00108	0.00138	CcSEcCtD
Fludarabine—Pain—Ibandronate—osteoporosis	0.00108	0.00138	CcSEcCtD
Fludarabine—Pruritus—Etidronic acid—osteoporosis	0.00108	0.00137	CcSEcCtD
Fludarabine—Acute coronary syndrome—Estradiol—osteoporosis	0.00108	0.00137	CcSEcCtD
Fludarabine—Decreased appetite—Calcitriol—osteoporosis	0.00108	0.00137	CcSEcCtD
Fludarabine—Neuropathy peripheral—Estradiol—osteoporosis	0.00107	0.00136	CcSEcCtD
Fludarabine—Myocardial infarction—Estradiol—osteoporosis	0.00107	0.00136	CcSEcCtD
Fludarabine—Feeling abnormal—Alendronate—osteoporosis	0.00107	0.00136	CcSEcCtD
Fludarabine—Oedema—Ethinyl Estradiol—osteoporosis	0.00107	0.00136	CcSEcCtD
Fludarabine—Malnutrition—Conjugated Estrogens—osteoporosis	0.00107	0.00136	CcSEcCtD
Fludarabine—Urinary tract infection—Estradiol—osteoporosis	0.00106	0.00135	CcSEcCtD
Fludarabine—Infection—Ethinyl Estradiol—osteoporosis	0.00106	0.00135	CcSEcCtD
Fludarabine—Cough—Pamidronate—osteoporosis	0.00106	0.00135	CcSEcCtD
Fludarabine—Pain—Calcitriol—osteoporosis	0.00106	0.00135	CcSEcCtD
Fludarabine—Constipation—Calcitriol—osteoporosis	0.00106	0.00135	CcSEcCtD
Fludarabine—Convulsion—Pamidronate—osteoporosis	0.00105	0.00134	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00105	0.00587	CbGpPWpGaD
Fludarabine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00105	0.00133	CcSEcCtD
Fludarabine—Diarrhoea—Etidronic acid—osteoporosis	0.00104	0.00133	CcSEcCtD
Fludarabine—Haematuria—Estradiol—osteoporosis	0.00104	0.00133	CcSEcCtD
Fludarabine—Body temperature increased—Estropipate—osteoporosis	0.00104	0.00133	CcSEcCtD
Fludarabine—Feeling abnormal—Ibandronate—osteoporosis	0.00104	0.00133	CcSEcCtD
Fludarabine—Infection—Risedronate—osteoporosis	0.00104	0.00132	CcSEcCtD
Fludarabine—Arthralgia—Pamidronate—osteoporosis	0.00104	0.00132	CcSEcCtD
Fludarabine—Myalgia—Pamidronate—osteoporosis	0.00104	0.00132	CcSEcCtD
Fludarabine—Epistaxis—Estradiol—osteoporosis	0.00103	0.00131	CcSEcCtD
Fludarabine—Ill-defined disorder—Zoledronate—osteoporosis	0.00103	0.00131	CcSEcCtD
Fludarabine—Body temperature increased—Alendronate—osteoporosis	0.00103	0.00131	CcSEcCtD
Fludarabine—Sinusitis—Estradiol—osteoporosis	0.00103	0.00131	CcSEcCtD
Fludarabine—Anaemia—Zoledronate—osteoporosis	0.00103	0.0013	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00103	0.00573	CbGpPWpGaD
Fludarabine—Nervous system disorder—Risedronate—osteoporosis	0.00102	0.0013	CcSEcCtD
Fludarabine—Discomfort—Pamidronate—osteoporosis	0.00102	0.0013	CcSEcCtD
Fludarabine—Agitation—Zoledronate—osteoporosis	0.00102	0.0013	CcSEcCtD
Fludarabine—Body temperature increased—Raloxifene—osteoporosis	0.00101	0.00129	CcSEcCtD
Fludarabine—Malaise—Zoledronate—osteoporosis	0.001	0.00127	CcSEcCtD
Fludarabine—Body temperature increased—Ibandronate—osteoporosis	0.001	0.00127	CcSEcCtD
Fludarabine—Confusional state—Pamidronate—osteoporosis	0.001	0.00127	CcSEcCtD
Fludarabine—Leukopenia—Zoledronate—osteoporosis	0.000994	0.00126	CcSEcCtD
Fludarabine—Oedema—Pamidronate—osteoporosis	0.000992	0.00126	CcSEcCtD
Fludarabine—Anaphylactic shock—Pamidronate—osteoporosis	0.000992	0.00126	CcSEcCtD
Fludarabine—Haemoglobin—Estradiol—osteoporosis	0.000988	0.00126	CcSEcCtD
Fludarabine—Infection—Pamidronate—osteoporosis	0.000986	0.00125	CcSEcCtD
Fludarabine—Haemorrhage—Estradiol—osteoporosis	0.000983	0.00125	CcSEcCtD
Fludarabine—Body temperature increased—Calcitriol—osteoporosis	0.00098	0.00125	CcSEcCtD
Fludarabine—Hypoaesthesia—Estradiol—osteoporosis	0.000978	0.00124	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000977	0.00545	CbGpPWpGaD
Fludarabine—Pharyngitis—Estradiol—osteoporosis	0.000976	0.00124	CcSEcCtD
Fludarabine—Hypersensitivity—Estropipate—osteoporosis	0.000973	0.00124	CcSEcCtD
Fludarabine—Nervous system disorder—Pamidronate—osteoporosis	0.000973	0.00124	CcSEcCtD
Fludarabine—Thrombocytopenia—Pamidronate—osteoporosis	0.000972	0.00123	CcSEcCtD
Fludarabine—Vomiting—Etidronic acid—osteoporosis	0.000971	0.00123	CcSEcCtD
Fludarabine—RRM1—Metabolism—FDPS—osteoporosis	0.000971	0.00542	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PKM—osteoporosis	0.000971	0.00542	CbGpPWpGaD
Fludarabine—Cough—Zoledronate—osteoporosis	0.000969	0.00123	CcSEcCtD
Fludarabine—Rash—Etidronic acid—osteoporosis	0.000963	0.00122	CcSEcCtD
Fludarabine—Convulsion—Zoledronate—osteoporosis	0.000962	0.00122	CcSEcCtD
Fludarabine—Dermatitis—Etidronic acid—osteoporosis	0.000962	0.00122	CcSEcCtD
Fludarabine—Hyperhidrosis—Pamidronate—osteoporosis	0.000959	0.00122	CcSEcCtD
Fludarabine—Hypersensitivity—Alendronate—osteoporosis	0.000958	0.00122	CcSEcCtD
Fludarabine—Headache—Etidronic acid—osteoporosis	0.000956	0.00122	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000951	0.00121	CcSEcCtD
Fludarabine—Asthenia—Estropipate—osteoporosis	0.000948	0.0012	CcSEcCtD
Fludarabine—Visual impairment—Estradiol—osteoporosis	0.000947	0.0012	CcSEcCtD
Fludarabine—Anorexia—Pamidronate—osteoporosis	0.000946	0.0012	CcSEcCtD
Fludarabine—Arthralgia—Zoledronate—osteoporosis	0.000945	0.0012	CcSEcCtD
Fludarabine—Myalgia—Zoledronate—osteoporosis	0.000945	0.0012	CcSEcCtD
Fludarabine—Paraesthesia—Risedronate—osteoporosis	0.000937	0.00119	CcSEcCtD
Fludarabine—Pruritus—Estropipate—osteoporosis	0.000934	0.00119	CcSEcCtD
Fludarabine—Discomfort—Zoledronate—osteoporosis	0.000934	0.00119	CcSEcCtD
Fludarabine—Asthenia—Alendronate—osteoporosis	0.000933	0.00119	CcSEcCtD
Fludarabine—Hypersensitivity—Ibandronate—osteoporosis	0.000933	0.00119	CcSEcCtD
Fludarabine—Cough—Conjugated Estrogens—osteoporosis	0.000933	0.00119	CcSEcCtD
Fludarabine—Dyspnoea—Risedronate—osteoporosis	0.000931	0.00118	CcSEcCtD
Fludarabine—Erythema multiforme—Estradiol—osteoporosis	0.00093	0.00118	CcSEcCtD
Fludarabine—Convulsion—Conjugated Estrogens—osteoporosis	0.000927	0.00118	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000924	0.00117	CcSEcCtD
Fludarabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000923	0.00117	CcSEcCtD
Fludarabine—Pruritus—Alendronate—osteoporosis	0.00092	0.00117	CcSEcCtD
Fludarabine—RRM1—Metabolism—GPD2—osteoporosis	0.00092	0.00513	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PGLS—osteoporosis	0.00092	0.00513	CbGpPWpGaD
Fludarabine—Dyspepsia—Risedronate—osteoporosis	0.000919	0.00117	CcSEcCtD
Fludarabine—Constipation—Ethinyl Estradiol—osteoporosis	0.000916	0.00116	CcSEcCtD
Fludarabine—Confusional state—Zoledronate—osteoporosis	0.000914	0.00116	CcSEcCtD
Fludarabine—Hypersensitivity—Calcitriol—osteoporosis	0.000913	0.00116	CcSEcCtD
Fludarabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00091	0.00116	CcSEcCtD
Fludarabine—Myalgia—Conjugated Estrogens—osteoporosis	0.00091	0.00116	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.00091	0.00508	CbGpPWpGaD
Fludarabine—Asthenia—Ibandronate—osteoporosis	0.000909	0.00115	CcSEcCtD
Fludarabine—Nausea—Etidronic acid—osteoporosis	0.000907	0.00115	CcSEcCtD
Fludarabine—Oedema—Zoledronate—osteoporosis	0.000906	0.00115	CcSEcCtD
Fludarabine—Anaphylactic shock—Zoledronate—osteoporosis	0.000906	0.00115	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000904	0.00115	CcSEcCtD
Fludarabine—Diarrhoea—Estropipate—osteoporosis	0.000904	0.00115	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000901	0.00115	CcSEcCtD
Fludarabine—Infection—Zoledronate—osteoporosis	0.0009	0.00114	CcSEcCtD
Fludarabine—Fatigue—Risedronate—osteoporosis	0.0009	0.00114	CcSEcCtD
Fludarabine—Pruritus—Ibandronate—osteoporosis	0.000896	0.00114	CcSEcCtD
Fludarabine—Constipation—Risedronate—osteoporosis	0.000893	0.00113	CcSEcCtD
Fludarabine—Pain—Risedronate—osteoporosis	0.000893	0.00113	CcSEcCtD
Fludarabine—Paraesthesia—Pamidronate—osteoporosis	0.000891	0.00113	CcSEcCtD
Fludarabine—Diarrhoea—Alendronate—osteoporosis	0.00089	0.00113	CcSEcCtD
Fludarabine—Asthenia—Calcitriol—osteoporosis	0.00089	0.00113	CcSEcCtD
Fludarabine—Nervous system disorder—Zoledronate—osteoporosis	0.000889	0.00113	CcSEcCtD
Fludarabine—Thrombocytopenia—Zoledronate—osteoporosis	0.000887	0.00113	CcSEcCtD
Fludarabine—Dyspnoea—Pamidronate—osteoporosis	0.000885	0.00112	CcSEcCtD
Fludarabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000882	0.00112	CcSEcCtD
Fludarabine—Chills—Estradiol—osteoporosis	0.000882	0.00112	CcSEcCtD
Fludarabine—Pruritus—Calcitriol—osteoporosis	0.000877	0.00111	CcSEcCtD
Fludarabine—Hyperhidrosis—Zoledronate—osteoporosis	0.000876	0.00111	CcSEcCtD
Fludarabine—Diarrhoea—Raloxifene—osteoporosis	0.000875	0.00111	CcSEcCtD
Fludarabine—Dyspepsia—Pamidronate—osteoporosis	0.000873	0.00111	CcSEcCtD
Fludarabine—Oedema—Conjugated Estrogens—osteoporosis	0.000873	0.00111	CcSEcCtD
Fludarabine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000873	0.00111	CcSEcCtD
Fludarabine—Alopecia—Estradiol—osteoporosis	0.000869	0.0011	CcSEcCtD
Fludarabine—Infection—Conjugated Estrogens—osteoporosis	0.000867	0.0011	CcSEcCtD
Fludarabine—Diarrhoea—Ibandronate—osteoporosis	0.000867	0.0011	CcSEcCtD
Fludarabine—Anorexia—Zoledronate—osteoporosis	0.000864	0.0011	CcSEcCtD
Fludarabine—Decreased appetite—Pamidronate—osteoporosis	0.000863	0.0011	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000857	0.00109	CcSEcCtD
Fludarabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000856	0.00109	CcSEcCtD
Fludarabine—Malnutrition—Estradiol—osteoporosis	0.000856	0.00109	CcSEcCtD
Fludarabine—Fatigue—Pamidronate—osteoporosis	0.000855	0.00109	CcSEcCtD
Fludarabine—Pain—Pamidronate—osteoporosis	0.000849	0.00108	CcSEcCtD
Fludarabine—Constipation—Pamidronate—osteoporosis	0.000849	0.00108	CcSEcCtD
Fludarabine—Diarrhoea—Calcitriol—osteoporosis	0.000848	0.00108	CcSEcCtD
Fludarabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000846	0.00108	CcSEcCtD
Fludarabine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000844	0.00107	CcSEcCtD
Fludarabine—RRM1—Metabolism—PNP—osteoporosis	0.000842	0.0047	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ATIC—osteoporosis	0.000842	0.0047	CbGpPWpGaD
Fludarabine—Vomiting—Estropipate—osteoporosis	0.00084	0.00107	CcSEcCtD
Fludarabine—Rash—Estropipate—osteoporosis	0.000833	0.00106	CcSEcCtD
Fludarabine—Dermatitis—Estropipate—osteoporosis	0.000832	0.00106	CcSEcCtD
Fludarabine—Anorexia—Conjugated Estrogens—osteoporosis	0.000832	0.00106	CcSEcCtD
Fludarabine—Headache—Estropipate—osteoporosis	0.000827	0.00105	CcSEcCtD
Fludarabine—Vomiting—Alendronate—osteoporosis	0.000827	0.00105	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000826	0.00105	CcSEcCtD
Fludarabine—Body temperature increased—Risedronate—osteoporosis	0.000825	0.00105	CcSEcCtD
Fludarabine—Rash—Alendronate—osteoporosis	0.00082	0.00104	CcSEcCtD
Fludarabine—Dermatitis—Alendronate—osteoporosis	0.000819	0.00104	CcSEcCtD
Fludarabine—Feeling abnormal—Pamidronate—osteoporosis	0.000818	0.00104	CcSEcCtD
Fludarabine—Headache—Alendronate—osteoporosis	0.000815	0.00104	CcSEcCtD
Fludarabine—Paraesthesia—Zoledronate—osteoporosis	0.000814	0.00103	CcSEcCtD
Fludarabine—Vomiting—Raloxifene—osteoporosis	0.000813	0.00103	CcSEcCtD
Fludarabine—Dyspnoea—Zoledronate—osteoporosis	0.000808	0.00103	CcSEcCtD
Fludarabine—Rash—Raloxifene—osteoporosis	0.000807	0.00103	CcSEcCtD
Fludarabine—Dermatitis—Raloxifene—osteoporosis	0.000806	0.00102	CcSEcCtD
Fludarabine—Vomiting—Ibandronate—osteoporosis	0.000805	0.00102	CcSEcCtD
Fludarabine—Headache—Raloxifene—osteoporosis	0.000802	0.00102	CcSEcCtD
Fludarabine—Rash—Ibandronate—osteoporosis	0.000799	0.00101	CcSEcCtD
Fludarabine—Dermatitis—Ibandronate—osteoporosis	0.000798	0.00101	CcSEcCtD
Fludarabine—Dyspepsia—Zoledronate—osteoporosis	0.000798	0.00101	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000795	0.00101	CcSEcCtD
Fludarabine—Ill-defined disorder—Estradiol—osteoporosis	0.000794	0.00101	CcSEcCtD
Fludarabine—Headache—Ibandronate—osteoporosis	0.000793	0.00101	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00079	0.00441	CbGpPWpGaD
Fludarabine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000789	0.001	CcSEcCtD
Fludarabine—Vomiting—Calcitriol—osteoporosis	0.000788	0.001	CcSEcCtD
Fludarabine—Decreased appetite—Zoledronate—osteoporosis	0.000788	0.001	CcSEcCtD
Fludarabine—Agitation—Estradiol—osteoporosis	0.000786	0.000999	CcSEcCtD
Fludarabine—Nausea—Estropipate—osteoporosis	0.000785	0.000997	CcSEcCtD
Fludarabine—Body temperature increased—Pamidronate—osteoporosis	0.000784	0.000997	CcSEcCtD
Fludarabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000784	0.000996	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000783	0.000994	CcSEcCtD
Fludarabine—Rash—Calcitriol—osteoporosis	0.000782	0.000993	CcSEcCtD
Fludarabine—Fatigue—Zoledronate—osteoporosis	0.000781	0.000993	CcSEcCtD
Fludarabine—Dermatitis—Calcitriol—osteoporosis	0.000781	0.000992	CcSEcCtD
Fludarabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000778	0.000989	CcSEcCtD
Fludarabine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000778	0.0375	CbGdCrCtD
Fludarabine—Headache—Calcitriol—osteoporosis	0.000777	0.000987	CcSEcCtD
Fludarabine—Pain—Zoledronate—osteoporosis	0.000775	0.000985	CcSEcCtD
Fludarabine—Constipation—Zoledronate—osteoporosis	0.000775	0.000985	CcSEcCtD
Fludarabine—Nausea—Alendronate—osteoporosis	0.000773	0.000982	CcSEcCtD
Fludarabine—Malaise—Estradiol—osteoporosis	0.000772	0.000981	CcSEcCtD
Fludarabine—Hypersensitivity—Risedronate—osteoporosis	0.000769	0.000977	CcSEcCtD
Fludarabine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000768	0.000976	CcSEcCtD
Fludarabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000768	0.000976	CcSEcCtD
Fludarabine—Nausea—Raloxifene—osteoporosis	0.00076	0.000966	CcSEcCtD
Fludarabine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000759	0.000964	CcSEcCtD
Fludarabine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000757	0.000962	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000753	0.000957	CcSEcCtD
Fludarabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000752	0.000956	CcSEcCtD
Fludarabine—Nausea—Ibandronate—osteoporosis	0.000752	0.000956	CcSEcCtD
Fludarabine—Asthenia—Risedronate—osteoporosis	0.000749	0.000952	CcSEcCtD
Fludarabine—Feeling abnormal—Zoledronate—osteoporosis	0.000747	0.000949	CcSEcCtD
Fludarabine—DCK—Metabolism—PKM—osteoporosis	0.000747	0.00417	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FDPS—osteoporosis	0.000747	0.00417	CbGpPWpGaD
Fludarabine—Cough—Estradiol—osteoporosis	0.000747	0.000949	CcSEcCtD
Fludarabine—Pain—Conjugated Estrogens—osteoporosis	0.000746	0.000948	CcSEcCtD
Fludarabine—Constipation—Conjugated Estrogens—osteoporosis	0.000746	0.000948	CcSEcCtD
Fludarabine—Pruritus—Risedronate—osteoporosis	0.000739	0.000938	CcSEcCtD
Fludarabine—Nausea—Calcitriol—osteoporosis	0.000736	0.000936	CcSEcCtD
Fludarabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000733	0.000931	CcSEcCtD
Fludarabine—Hypersensitivity—Pamidronate—osteoporosis	0.000731	0.000929	CcSEcCtD
Fludarabine—Myalgia—Estradiol—osteoporosis	0.000729	0.000926	CcSEcCtD
Fludarabine—Arthralgia—Estradiol—osteoporosis	0.000729	0.000926	CcSEcCtD
Fludarabine—Discomfort—Estradiol—osteoporosis	0.00072	0.000915	CcSEcCtD
Fludarabine—Body temperature increased—Zoledronate—osteoporosis	0.000717	0.00091	CcSEcCtD
Fludarabine—RRM1—Metabolism—OXCT1—osteoporosis	0.000716	0.00399	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CA2—osteoporosis	0.000716	0.00399	CbGpPWpGaD
Fludarabine—Diarrhoea—Risedronate—osteoporosis	0.000714	0.000908	CcSEcCtD
Fludarabine—Asthenia—Pamidronate—osteoporosis	0.000712	0.000905	CcSEcCtD
Fludarabine—DCK—Metabolism—GPD2—osteoporosis	0.000708	0.00395	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PGLS—osteoporosis	0.000708	0.00395	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PSMA5—osteoporosis	0.000708	0.00395	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PSMA2—osteoporosis	0.000708	0.00395	CbGpPWpGaD
Fludarabine—Confusional state—Estradiol—osteoporosis	0.000704	0.000895	CcSEcCtD
Fludarabine—Pruritus—Pamidronate—osteoporosis	0.000702	0.000892	CcSEcCtD
Fludarabine—Oedema—Estradiol—osteoporosis	0.000698	0.000888	CcSEcCtD
Fludarabine—Anaphylactic shock—Estradiol—osteoporosis	0.000698	0.000888	CcSEcCtD
Fludarabine—RRM1—Metabolism—MGLL—osteoporosis	0.000697	0.00389	CbGpPWpGaD
Fludarabine—Infection—Estradiol—osteoporosis	0.000694	0.000882	CcSEcCtD
Fludarabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00069	0.000877	CcSEcCtD
Fludarabine—Nervous system disorder—Estradiol—osteoporosis	0.000685	0.00087	CcSEcCtD
Fludarabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000681	0.000865	CcSEcCtD
Fludarabine—Diarrhoea—Pamidronate—osteoporosis	0.000679	0.000863	CcSEcCtD
Fludarabine—Hyperhidrosis—Estradiol—osteoporosis	0.000675	0.000858	CcSEcCtD
Fludarabine—Rash—Ethinyl Estradiol—osteoporosis	0.000675	0.000858	CcSEcCtD
Fludarabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000674	0.000857	CcSEcCtD
Fludarabine—Headache—Ethinyl Estradiol—osteoporosis	0.000671	0.000852	CcSEcCtD
Fludarabine—Hypersensitivity—Zoledronate—osteoporosis	0.000668	0.000849	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—MYC—osteoporosis	0.000665	0.00371	CbGpPWpGaD
Fludarabine—Vomiting—Risedronate—osteoporosis	0.000664	0.000843	CcSEcCtD
Fludarabine—Rash—Risedronate—osteoporosis	0.000658	0.000836	CcSEcCtD
Fludarabine—Dermatitis—Risedronate—osteoporosis	0.000658	0.000836	CcSEcCtD
Fludarabine—Headache—Risedronate—osteoporosis	0.000654	0.000831	CcSEcCtD
Fludarabine—Asthenia—Zoledronate—osteoporosis	0.00065	0.000826	CcSEcCtD
Fludarabine—DCK—Metabolism—ATIC—osteoporosis	0.000648	0.00361	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PNP—osteoporosis	0.000648	0.00361	CbGpPWpGaD
Fludarabine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000643	0.000817	CcSEcCtD
Fludarabine—Pruritus—Zoledronate—osteoporosis	0.000641	0.000815	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000636	0.000809	CcSEcCtD
Fludarabine—Nausea—Ethinyl Estradiol—osteoporosis	0.000636	0.000808	CcSEcCtD
Fludarabine—Vomiting—Pamidronate—osteoporosis	0.000631	0.000802	CcSEcCtD
Fludarabine—Paraesthesia—Estradiol—osteoporosis	0.000627	0.000797	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000627	0.0035	CbGpPWpGaD
Fludarabine—Asthenia—Conjugated Estrogens—osteoporosis	0.000626	0.000796	CcSEcCtD
Fludarabine—Rash—Pamidronate—osteoporosis	0.000626	0.000795	CcSEcCtD
Fludarabine—Dermatitis—Pamidronate—osteoporosis	0.000625	0.000794	CcSEcCtD
Fludarabine—Dyspnoea—Estradiol—osteoporosis	0.000623	0.000791	CcSEcCtD
Fludarabine—Headache—Pamidronate—osteoporosis	0.000622	0.00079	CcSEcCtD
Fludarabine—Diarrhoea—Zoledronate—osteoporosis	0.00062	0.000788	CcSEcCtD
Fludarabine—Nausea—Risedronate—osteoporosis	0.00062	0.000788	CcSEcCtD
Fludarabine—Pruritus—Conjugated Estrogens—osteoporosis	0.000617	0.000785	CcSEcCtD
Fludarabine—Dyspepsia—Estradiol—osteoporosis	0.000615	0.000781	CcSEcCtD
Fludarabine—Decreased appetite—Estradiol—osteoporosis	0.000607	0.000772	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000603	0.000766	CcSEcCtD
Fludarabine—Fatigue—Estradiol—osteoporosis	0.000602	0.000765	CcSEcCtD
Fludarabine—Constipation—Estradiol—osteoporosis	0.000597	0.000759	CcSEcCtD
Fludarabine—Pain—Estradiol—osteoporosis	0.000597	0.000759	CcSEcCtD
Fludarabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000597	0.000759	CcSEcCtD
Fludarabine—RRM1—Metabolism—IDH2—osteoporosis	0.000593	0.00331	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000592	0.00331	CbGpPWpGaD
Fludarabine—Nausea—Pamidronate—osteoporosis	0.000589	0.000749	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000578	0.00323	CbGpPWpGaD
Fludarabine—Vomiting—Zoledronate—osteoporosis	0.000576	0.000732	CcSEcCtD
Fludarabine—Feeling abnormal—Estradiol—osteoporosis	0.000576	0.000731	CcSEcCtD
Fludarabine—Rash—Zoledronate—osteoporosis	0.000571	0.000726	CcSEcCtD
Fludarabine—Dermatitis—Zoledronate—osteoporosis	0.000571	0.000726	CcSEcCtD
Fludarabine—Headache—Zoledronate—osteoporosis	0.000568	0.000722	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP27A1—osteoporosis	0.000557	0.00311	CbGpPWpGaD
Fludarabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000555	0.000705	CcSEcCtD
Fludarabine—Body temperature increased—Estradiol—osteoporosis	0.000552	0.000702	CcSEcCtD
Fludarabine—DCK—Metabolism—CA2—osteoporosis	0.000551	0.00307	CbGpPWpGaD
Fludarabine—DCK—Metabolism—OXCT1—osteoporosis	0.000551	0.00307	CbGpPWpGaD
Fludarabine—Rash—Conjugated Estrogens—osteoporosis	0.00055	0.000699	CcSEcCtD
Fludarabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00055	0.000699	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000547	0.00305	CbGpPWpGaD
Fludarabine—Headache—Conjugated Estrogens—osteoporosis	0.000547	0.000695	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000546	0.00305	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ACP5—osteoporosis	0.000542	0.00303	CbGpPWpGaD
Fludarabine—Nausea—Zoledronate—osteoporosis	0.000538	0.000684	CcSEcCtD
Fludarabine—DCK—Metabolism—MGLL—osteoporosis	0.000537	0.00299	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000529	0.00295	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000529	0.00295	CbGpPWpGaD
Fludarabine—Nausea—Conjugated Estrogens—osteoporosis	0.000518	0.000659	CcSEcCtD
Fludarabine—Hypersensitivity—Estradiol—osteoporosis	0.000515	0.000654	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000513	0.00286	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.00051	0.00284	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TPI1—osteoporosis	0.000504	0.00281	CbGpPWpGaD
Fludarabine—Asthenia—Estradiol—osteoporosis	0.000501	0.000637	CcSEcCtD
Fludarabine—Pruritus—Estradiol—osteoporosis	0.000494	0.000628	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—osteoporosis	0.000483	0.00269	CbGpPWpGaD
Fludarabine—Diarrhoea—Estradiol—osteoporosis	0.000478	0.000607	CcSEcCtD
Fludarabine—RRM1—Metabolism—P4HB—osteoporosis	0.000474	0.00264	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PSMA2—osteoporosis	0.000473	0.00264	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PSMA5—osteoporosis	0.000473	0.00264	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000467	0.00261	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GAPDH—osteoporosis	0.000465	0.0026	CbGpPWpGaD
Fludarabine—DCK—Metabolism—IDH2—osteoporosis	0.000456	0.00255	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—RAP1A—osteoporosis	0.000453	0.00253	CbGpPWpGaD
Fludarabine—Vomiting—Estradiol—osteoporosis	0.000444	0.000564	CcSEcCtD
Fludarabine—Rash—Estradiol—osteoporosis	0.00044	0.00056	CcSEcCtD
Fludarabine—Dermatitis—Estradiol—osteoporosis	0.00044	0.000559	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—osteoporosis	0.000438	0.00244	CbGpPWpGaD
Fludarabine—Headache—Estradiol—osteoporosis	0.000438	0.000556	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP27A1—osteoporosis	0.000429	0.00239	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACP5—osteoporosis	0.000417	0.00233	CbGpPWpGaD
Fludarabine—Nausea—Estradiol—osteoporosis	0.000415	0.000527	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000407	0.00227	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TPI1—osteoporosis	0.000388	0.00216	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO1—osteoporosis	0.000366	0.00204	CbGpPWpGaD
Fludarabine—DCK—Metabolism—P4HB—osteoporosis	0.000365	0.00204	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PSMA2—osteoporosis	0.000361	0.00201	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PSMA5—osteoporosis	0.000361	0.00201	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GAPDH—osteoporosis	0.000358	0.002	CbGpPWpGaD
Fludarabine—DCK—Metabolism—RAP1A—osteoporosis	0.000349	0.00195	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000308	0.00172	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000307	0.00172	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP19A1—osteoporosis	0.000293	0.00163	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000287	0.0016	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENO1—osteoporosis	0.000282	0.00157	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PSMA2—osteoporosis	0.000278	0.00155	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PSMA5—osteoporosis	0.000278	0.00155	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ADCY5—osteoporosis	0.000239	0.00134	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPX1—osteoporosis	0.000238	0.00133	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP19A1—osteoporosis	0.000225	0.00126	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—osteoporosis	0.00022	0.00123	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADCY5—osteoporosis	0.000184	0.00103	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX1—osteoporosis	0.000183	0.00102	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—POMC—osteoporosis	0.000176	0.000982	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—osteoporosis	0.000169	0.000945	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—osteoporosis	0.000149	0.000832	CbGpPWpGaD
Fludarabine—DCK—Metabolism—POMC—osteoporosis	0.000135	0.000756	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—osteoporosis	0.000133	0.000744	CbGpPWpGaD
